

Abamune L Tablet (Abacavir and Lamivudine)
Manufactured By
Cipla
Pack Of
30
Salt Composition
Abacavir and Lamivudine
Storage
Keep in cold place
Overview
Abamune L Tablet is an antiretrovirals medicine contains Abacavir and Lamivudine
as an active ingredients. It is prescribed to treat HIV (human immunodeficiency virus) infection. This medicine prevents the multiplication of HIV and reduces the viral load in the body. Moreover, this tablet boosts immune functioning to fight against HIV infection. Always take it under medical supervision.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | abamune l |
| Generic / Active Ingredient | Abacavir/Lamivudine |
| Strength | 600 |
| Dosage Form | Tablet |
| Manufacturer / Marketer | cipla |
| Pack Size | 30 |
| Prescription Required | Yes |
| Therapeutic Categories | HIV Medicines |
| Uses | HIV |
Uses and Indications
HIV
Side Effects of Abamune L Tablet
Abamune L Tablet(Abacavir and Lamivudine) is a strong anti-HIV medicine that may show certain adverse while manageable impact on the body during the treatment. As these effects resolve on their own without any special medical attention. However, if you ever experience serious or unusual side effects contact your healthcare professional immediately.
Some common side effects include:
● Headache
● Vomiting
● Fever
● Lethargy
● Decreased appetite
● Dizziness
● Muscle pain
● Hypersensitivity
● Altered liver function test
● Abdominal pain
● Abnormal dreams
● Rash
● Nausea
● Sleep disorder
● Ear, nose, and throat (ENT) infections
● Fatigue
● Diarrhea
Abamune L Tablet Dosage and How To Take It
Doctor determines the dosage and duration of Abamune L Tablet(Abacavir and Lamivudine) as per the type of disease and overall health condition of the patients. Do not crush or break the tablet. This tablet may be taken with or without food. In case of an overdose, the doctor will provide emergency medical treatment. Do not stop or change the dose without informing your doctor.
Safety Advice for Abamune L Tablet
- ● Alcohol: Avoid the consumption of alcohol while taking Abamune L Tablet(Abacavir and Lamivudine), as alcohol can decrease the effectiveness of the medicine as well as worsen the symptoms
- ● Pregnancy: Do not take Abamune L Tablet without consulting the doctor in case of pregnancy, as it is an unsafe to take it during this period.
- ● Breastfeeding: Abamune L Tablet(Abacavir and Lamivudine) is safe to use while breastfeeding, if prescribed by the doctor. No dosage adjustment is necessary for this tablet as limited data is available that shows significant risk.
- ● Driving: Abamune L Tablet is safe to use while driving as it does not usually affect your ability to drive.
- ● Kidney: Abamune L Tablet(Abacavir and Lamivudine) is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
- ● Liver: Share your medical history with the doctor before starting the treatment with Abamune L Tablet(Abacavir and Lamivudine). Do not take it without consulting a doctor if you have any liver related issue.
FAQs About Abamune L Tablet
How does Abamune L Tablet(Abacavir and Lamivudine) work?
It is an antiretroviral medicine. Abamune L Tablet works by reducing the viral load in the body and preventing further multiplication of virus.
Are there any side effects of taking Abamune L Tablet?
Yes there are some common side effects of taking Abamune L Tablet(Abacavir and Lamivudine) such as headache, vomiting, fever, lethargy, decreased appetite, dizziness, muscle pain, hypersensitivity, etc.
What is the use of Abamune L Tablet?
Abamune L Tablet(Abacavir and Lamivudine) is an antiviral medicine prescribed to treat HIV (human immunodeficiency virus) infection and manage AIDS.
What is the salt composition of Abamune L Tablet?
Abamune L Tablet is an antiretroviral medicine which consist Abacavir as an active ingredient.
Is the consumption of Abamune L Tablet(Abacavir and Lamivudine) safe while breastfeeding?
Consumption of Abamune L Tablet is probably consider to safe while breastfeeding as there is no strong evidence available to support its harmful effects.
References
● Dando, T. M., & Scott, L. J. (2005). Abacavir plus lamivudine: a review of their combined use in the management of HIV infection. Drugs, 65(2), 285-302.
● Ibbotson, T., & Perry, C. M. (2003). Lamivudine/zidovudine/abacavir: triple combination tablet. Drugs, 63(11), 1089-1098.
● Sivasubramanian, G., Frempong-Manso, E., & MacArthur, R. D. (2010). Abacavir/lamivudine combination in the treatment of HIV: a review. Therapeutics and clinical risk management, 83-94.
● Weller, S., Chen, S., Borland, J., Savina, P., Wynne, B., & Piscitelli, S. C. (2014). Bioequivalence of a dolutegravir, abacavir, and lamivudine fixed-dose combination tablet and the effect of food. JAIDS Journal of Acquired Immune Deficiency Syndromes, 66(4), 393-398.
● Rizzardini, G., & Zucchi, P. (2011). Abacavir and lamivudine for the treatment of human immunodeficiency virus. Expert opinion on pharmacotherapy, 12(13), 2129-2138.
● Greig, S. L., & Deeks, E. D. (2015). Abacavir/dolutegravir/lamivudine single-tablet regimen: a review of its use in HIV-1 infection. Drugs, 75(5), 503-514.
Marketer Details
Cipla
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.


